感染症治療薬の世界市場 2020年

• 英文タイトル：Global Infectious Disease Drugs Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201115665 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、感染症治療薬の世界市場を調査対象にし、感染症治療薬の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（抗菌剤、抗ウイルス剤、駆虫剤、抗真菌剤、その他）、用途別分析（HIV、マラリア、肝炎、インフルエンザ、HPV、結核、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：GlaxoSmithKline、Grifols、Pfizer、Gilead Sciences、Shire、Merck & Co.、Protein Sciences、AbbVie、Sanofi、Johnson & Johnson、AstraZeneca ・企業別売上、市場シェア ・感染症治療薬の地域別市場分析 ・感染症治療薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・感染症治療薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・感染症治療薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・感染症治療薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・感染症治療薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・感染症治療薬の種類別市場規模2015-2020：抗菌剤、抗ウイルス剤、駆虫剤、抗真菌剤、その他 ・感染症治療薬の用途別市場規模2015-2020：HIV、マラリア、肝炎、インフルエンザ、HPV、結核、その他 ・感染症治療薬の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Infectious Disease Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Infectious Disease Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Infectious Disease Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Infectious Disease Drugs market has been segmented into:
Antibacterials
Antiviral drugs
Antiparasitic drugs
Antifungal
Others

By Application, Infectious Disease Drugs has been segmented into:
HIV
Malaria
Hepatitis
Influenza
HPV
Tuberculosis
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Infectious Disease Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Infectious Disease Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Infectious Disease Drugs market.

The report offers in-depth assessment of the growth and other aspects of the Infectious Disease Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Infectious Disease Drugs Market Share Analysis
Infectious Disease Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Infectious Disease Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Infectious Disease Drugs sales, revenue and market share for each player covered in this report.

The major players covered in Infectious Disease Drugs are:
GlaxoSmithKline
Grifols
Pfizer
Gilead Sciences
Shire
Merck & Co.
Protein Sciences
AbbVie
Sanofi
Johnson & Johnson
AstraZeneca

レポート目次

---

Table of Contents

1 Infectious Disease Drugs Market Overview
1.1 Product Overview and Scope of Infectious Disease Drugs
1.2 Classification of Infectious Disease Drugs by Type
1.2.1 Global Infectious Disease Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Infectious Disease Drugs Revenue Market Share by Type in 2019
1.2.3 Antibacterials
1.2.4 Antiviral drugs
1.2.5 Antiparasitic drugs
1.2.6 Antifungal
1.2.7 Others
1.3 Global Infectious Disease Drugs Market by Application
1.3.1 Overview: Global Infectious Disease Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 HIV
1.3.3 Malaria
1.3.4 Hepatitis
1.3.5 Influenza
1.3.6 HPV
1.3.7 Tuberculosis
1.3.8 Others
1.4 Global Infectious Disease Drugs Market by Regions
1.4.1 Global Infectious Disease Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Infectious Disease Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Infectious Disease Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Infectious Disease Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Infectious Disease Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Infectious Disease Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Infectious Disease Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GlaxoSmithKline SWOT Analysis
2.1.4 GlaxoSmithKline Product and Services
2.1.5 GlaxoSmithKline Infectious Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Grifols
2.2.1 Grifols Details
2.2.2 Grifols Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Grifols SWOT Analysis
2.2.4 Grifols Product and Services
2.2.5 Grifols Infectious Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer SWOT Analysis
2.3.4 Pfizer Product and Services
2.3.5 Pfizer Infectious Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 Gilead Sciences
2.4.1 Gilead Sciences Details
2.4.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Gilead Sciences SWOT Analysis
2.4.4 Gilead Sciences Product and Services
2.4.5 Gilead Sciences Infectious Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 Shire
2.5.1 Shire Details
2.5.2 Shire Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Shire SWOT Analysis
2.5.4 Shire Product and Services
2.5.5 Shire Infectious Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck & Co.
2.6.1 Merck & Co. Details
2.6.2 Merck & Co. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck & Co. SWOT Analysis
2.6.4 Merck & Co. Product and Services
2.6.5 Merck & Co. Infectious Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Protein Sciences
2.7.1 Protein Sciences Details
2.7.2 Protein Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Protein Sciences SWOT Analysis
2.7.4 Protein Sciences Product and Services
2.7.5 Protein Sciences Infectious Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 AbbVie
2.8.1 AbbVie Details
2.8.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AbbVie SWOT Analysis
2.8.4 AbbVie Product and Services
2.8.5 AbbVie Infectious Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Sanofi SWOT Analysis
2.9.4 Sanofi Product and Services
2.9.5 Sanofi Infectious Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.10 Johnson & Johnson
2.10.1 Johnson & Johnson Details
2.10.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Johnson & Johnson SWOT Analysis
2.10.4 Johnson & Johnson Product and Services
2.10.5 Johnson & Johnson Infectious Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.11 AstraZeneca
2.11.1 AstraZeneca Details
2.11.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 AstraZeneca SWOT Analysis
2.11.4 AstraZeneca Product and Services
2.11.5 AstraZeneca Infectious Disease Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Infectious Disease Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Infectious Disease Drugs Players Market Share
3.2.2 Top 10 Infectious Disease Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Infectious Disease Drugs Revenue and Market Share by Regions
4.2 North America Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
5 North America Infectious Disease Drugs Revenue by Countries
5.1 North America Infectious Disease Drugs Revenue by Countries (2015-2020)
5.2 USA Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
6 Europe Infectious Disease Drugs Revenue by Countries
6.1 Europe Infectious Disease Drugs Revenue by Countries (2015-2020)
6.2 Germany Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
6.4 France Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Infectious Disease Drugs Revenue by Countries
7.1 Asia-Pacific Infectious Disease Drugs Revenue by Countries (2015-2020)
7.2 China Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
7.5 India Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
8 South America Infectious Disease Drugs Revenue by Countries
8.1 South America Infectious Disease Drugs Revenue by Countries (2015-2020)
8.2 Brazil Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Infectious Disease Drugs by Countries
9.1 Middle East & Africa Infectious Disease Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Infectious Disease Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Infectious Disease Drugs Market Forecast by Type (2019-2024)
10.3 Antibacterials Revenue Growth Rate (2015-2025)
10.4 Antiviral drugs Revenue Growth Rate (2015-2025)
10.5 Antiparasitic drugs Revenue Growth Rate (2015-2025)
10.6 Antifungal Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Infectious Disease Drugs Market Segment by Application
11.1 Global Infectious Disease Drugs Revenue Market Share by Application (2015-2020)
11.2 Infectious Disease Drugs Market Forecast by Application (2019-2024)
11.3 HIV Revenue Growth (2015-2020)
11.4 Malaria Revenue Growth (2015-2020)
11.5 Hepatitis Revenue Growth (2015-2020)
11.6 Influenza Revenue Growth (2015-2020)
11.7 HPV Revenue Growth (2015-2020)
11.8 Tuberculosis Revenue Growth (2015-2020)
11.9 Others Revenue Growth (2015-2020)
12 Global Infectious Disease Drugs Market Size Forecast (2021-2025)
12.1 Global Infectious Disease Drugs Market Size Forecast (2021-2025)
12.2 Global Infectious Disease Drugs Market Forecast by Regions (2021-2025)
12.3 North America Infectious Disease Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Infectious Disease Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Infectious Disease Drugs Revenue Market Forecast (2021-2025)
12.6 South America Infectious Disease Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Infectious Disease Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Infectious Disease Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Infectious Disease Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Infectious Disease Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Infectious Disease Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. GlaxoSmithKline Corporate Information, Location and Competitors
Table 6. GlaxoSmithKline Infectious Disease Drugs Major Business
Table 7. GlaxoSmithKline Infectious Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 8. GlaxoSmithKline SWOT Analysis
Table 9. GlaxoSmithKline Infectious Disease Drugs Product and Solutions
Table 10. GlaxoSmithKline Infectious Disease Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Grifols Corporate Information, Location and Competitors
Table 12. Grifols Infectious Disease Drugs Major Business
Table 13. Grifols Infectious Disease Drugs Total Revenue (USD Million) (2018-2019)
Table 14. Grifols SWOT Analysis
Table 15. Grifols Infectious Disease Drugs Product and Solutions
Table 16. Grifols Infectious Disease Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Pfizer Corporate Information, Location and Competitors
Table 18. Pfizer Infectious Disease Drugs Major Business
Table 19. Pfizer Infectious Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 20. Pfizer SWOT Analysis
Table 21. Pfizer Infectious Disease Drugs Product and Solutions
Table 22. Pfizer Infectious Disease Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Gilead Sciences Corporate Information, Location and Competitors
Table 24. Gilead Sciences Infectious Disease Drugs Major Business
Table 25. Gilead Sciences Infectious Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 26. Gilead Sciences SWOT Analysis
Table 27. Gilead Sciences Infectious Disease Drugs Product and Solutions
Table 28. Gilead Sciences Infectious Disease Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Shire Corporate Information, Location and Competitors
Table 30. Shire Infectious Disease Drugs Major Business
Table 31. Shire Infectious Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 32. Shire SWOT Analysis
Table 33. Shire Infectious Disease Drugs Product and Solutions
Table 34. Shire Infectious Disease Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Merck & Co. Corporate Information, Location and Competitors
Table 36. Merck & Co. Infectious Disease Drugs Major Business
Table 37. Merck & Co. Infectious Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 38. Merck & Co. SWOT Analysis
Table 39. Merck & Co. Infectious Disease Drugs Product and Solutions
Table 40. Merck & Co. Infectious Disease Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Protein Sciences Corporate Information, Location and Competitors
Table 42. Protein Sciences Infectious Disease Drugs Major Business
Table 43. Protein Sciences Infectious Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 44. Protein Sciences SWOT Analysis
Table 45. Protein Sciences Infectious Disease Drugs Product and Solutions
Table 46. Protein Sciences Infectious Disease Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. AbbVie Corporate Information, Location and Competitors
Table 48. AbbVie Infectious Disease Drugs Major Business
Table 49. AbbVie Infectious Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 50. AbbVie SWOT Analysis
Table 51. AbbVie Infectious Disease Drugs Product and Solutions
Table 52. AbbVie Infectious Disease Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Sanofi Corporate Information, Location and Competitors
Table 54. Sanofi Infectious Disease Drugs Major Business
Table 55. Sanofi Infectious Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 56. Sanofi SWOT Analysis
Table 57. Sanofi Infectious Disease Drugs Product and Solutions
Table 58. Sanofi Infectious Disease Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Johnson & Johnson Corporate Information, Location and Competitors
Table 60. Johnson & Johnson Infectious Disease Drugs Major Business
Table 61. Johnson & Johnson Infectious Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 62. Johnson & Johnson SWOT Analysis
Table 63. Johnson & Johnson Infectious Disease Drugs Product and Solutions
Table 64. Johnson & Johnson Infectious Disease Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. AstraZeneca Corporate Information, Location and Competitors
Table 66. AstraZeneca Infectious Disease Drugs Major Business
Table 67. AstraZeneca Infectious Disease Drugs Total Revenue (USD Million) (2017-2018)
Table 68. AstraZeneca SWOT Analysis
Table 69. AstraZeneca Infectious Disease Drugs Product and Solutions
Table 70. AstraZeneca Infectious Disease Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Global Infectious Disease Drugs Revenue (Million USD) by Players (2015-2020)
Table 72. Global Infectious Disease Drugs Revenue Share by Players (2015-2020)
Table 73. Global Infectious Disease Drugs Revenue (Million USD) by Regions (2015-2020)
Table 74. Global Infectious Disease Drugs Revenue Market Share by Regions (2015-2020)
Table 75. North America Infectious Disease Drugs Revenue by Countries (2015-2020)
Table 76. North America Infectious Disease Drugs Revenue Market Share by Countries (2015-2020)
Table 77. Europe Infectious Disease Drugs Revenue (Million USD) by Countries (2015-2020)
Table 78. Asia-Pacific Infectious Disease Drugs Revenue (Million USD) by Countries (2015-2020)
Table 79. South America Infectious Disease Drugs Revenue by Countries (2015-2020)
Table 80. South America Infectious Disease Drugs Revenue Market Share by Countries (2015-2020)
Table 81. Middle East and Africa Infectious Disease Drugs Revenue (Million USD) by Countries (2015-2020)
Table 82. Middle East and Africa Infectious Disease Drugs Revenue Market Share by Countries (2015-2020)
Table 83. Global Infectious Disease Drugs Revenue (Million USD) by Type (2015-2020)
Table 84. Global Infectious Disease Drugs Revenue Share by Type (2015-2020)
Table 85. Global Infectious Disease Drugs Revenue Forecast by Type (2021-2025)
Table 86. Global Infectious Disease Drugs Revenue by Application (2015-2020)
Table 87. Global Infectious Disease Drugs Revenue Share by Application (2015-2020)
Table 88. Global Infectious Disease Drugs Revenue Forecast by Application (2021-2025)
Table 89. Global Infectious Disease Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Infectious Disease Drugs Picture
Figure 2. Global Infectious Disease Drugs Revenue Market Share by Type in 2019
Figure 3. Antibacterials Picture
Figure 4. Antiviral drugs Picture
Figure 5. Antiparasitic drugs Picture
Figure 6. Antifungal Picture
Figure 7. Others Picture
Figure 8. Infectious Disease Drugs Revenue Market Share by Application in 2019
Figure 9. HIV Picture
Figure 10. Malaria Picture
Figure 11. Hepatitis Picture
Figure 12. Influenza Picture
Figure 13. HPV Picture
Figure 14. Tuberculosis Picture
Figure 15. Others Picture
Figure 16. Global Infectious Disease Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 17. North America Infectious Disease Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Europe Infectious Disease Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Asia-Pacific Infectious Disease Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. South America Infectious Disease Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Middle East and Africa Infectious Disease Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Infectious Disease Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. Global Infectious Disease Drugs Revenue Share by Players in 2019
Figure 24. Global Top 5 Players Infectious Disease Drugs Revenue Market Share in 2019
Figure 25. Global Top 10 Players Infectious Disease Drugs Revenue Market Share in 2019
Figure 26. Key Players Market Share Trend
Figure 27. Global Infectious Disease Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 28. Global Infectious Disease Drugs Revenue Market Share by Regions (2015-2020)
Figure 29. Global Infectious Disease Drugs Revenue Market Share by Regions in 2018
Figure 30. North America Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 31. Europe Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 32. Asia-Pacific Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 33. South America Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 34. Middle East and Africa Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 35. North America Infectious Disease Drugs Revenue Market Share by Countries (2015-2020)
Figure 36. North America Infectious Disease Drugs Revenue Market Share by Countries in 2019
Figure 37. USA Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 38. Canada Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 39. Mexico Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 40. Europe Infectious Disease Drugs Revenue Market Share by Countries (2015-2020)
Figure 41. Europe Infectious Disease Drugs Revenue Market Share by Countries in 2019
Figure 42. Germany Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 43. UK Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 44. France Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 45. Russia Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 46. Italy Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Infectious Disease Drugs Revenue Market Share by Countries (2015-2020)
Figure 48. Asia-Pacific Infectious Disease Drugs Revenue Market Share by Countries in 2019
Figure 49. China Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 50. Japan Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 51. Korea Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 52. India Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 53. Southeast Asia Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 54. South America Infectious Disease Drugs Revenue Market Share by Countries (2015-2020)
Figure 55. South America Infectious Disease Drugs Revenue Market Share by Countries in 2019
Figure 56. Brazil Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 57. Argentina Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 58. Middle East and Africa Infectious Disease Drugs Revenue Market Share by Countries (2015-2020)
Figure 59. Middle East and Africa Infectious Disease Drugs Revenue Market Share by Countries in 2019
Figure 60. Saudi Arabia Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 61. UAE Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 62. Egypt Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 63. South Africa Infectious Disease Drugs Revenue and Growth Rate (2015-2020)
Figure 64. Global Infectious Disease Drugs Revenue Share by Type (2015-2020)
Figure 65. Global Infectious Disease Drugs Revenue Share by Type in 2019
Figure 66. Global Infectious Disease Drugs Market Share Forecast by Type (2021-2025)
Figure 67. Global Antibacterials Revenue Growth Rate (2015-2020)
Figure 68. Global Antiviral drugs Revenue Growth Rate (2015-2020)
Figure 69. Global Antiparasitic drugs Revenue Growth Rate (2015-2020)
Figure 70. Global Antifungal Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Infectious Disease Drugs Revenue Share by Application (2015-2020)
Figure 73. Global Infectious Disease Drugs Revenue Share by Application in 2019
Figure 74. Global Infectious Disease Drugs Market Share Forecast by Application (2021-2025)
Figure 75. Global HIV Revenue Growth Rate (2015-2020)
Figure 76. Global Malaria Revenue Growth Rate (2015-2020)
Figure 77. Global Hepatitis Revenue Growth Rate (2015-2020)
Figure 78. Global Influenza Revenue Growth Rate (2015-2020)
Figure 79. Global HPV Revenue Growth Rate (2015-2020)
Figure 80. Global Tuberculosis Revenue Growth Rate (2015-2020)
Figure 81. Global Others Revenue Growth Rate (2015-2020)
Figure 82. Global Infectious Disease Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 83. Global Infectious Disease Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 84. Global Infectious Disease Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 85. North America Infectious Disease Drugs Revenue Market Forecast (2021-2025)
Figure 86. Europe Infectious Disease Drugs Revenue Market Forecast (2021-2025)
Figure 87. Asia-Pacific Infectious Disease Drugs Revenue Market Forecast (2021-2025)
Figure 88. South America Infectious Disease Drugs Revenue Market Forecast (2021-2025)
Figure 89. Middle East and Africa Infectious Disease Drugs Revenue Market Forecast (2021-2025)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel

---